Eugene Schneider sold $1.2M of Ionis Pharmaceuticals (IONS)

Executed Sep 3 2025, disclosed Sep 4 2025, 1 day later.

Value, as filed

$1.2M

19,658 sh across 2 lots

Executed

Sep 3 2025

the trade date, as filed

Disclosed

Sep 4 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

ES Eugene Schneider EVP, Chf Clinical Develop Ofcr profile →

Eugene Schneider (EVP, Chf Clinical Develop Ofcr) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Ionis Pharmaceuticals, Inc. (IONS). The largest single filing was $2.1M of IONS (26,000 sh × $81.05, as filed), executed Jun 26.

The name

IONS Ionis Pharmaceuticals, Inc. IONS · Healthcare · 119 filings in 24 months ticker →

Healthcare · Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Eugene Schneider in IONS

IONSSALE Ionis Pharmaceuticals, Inc. $2.1M
26,000 sh × $81.05
Exec Jun 26
Filed Jun 30 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $412K
5,812 sh × $70.97
Exec Mar 19
Filed Mar 23 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $516K
6,179 sh × $83.45
Exec Jan 30
Filed Feb 2 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $703K
9,302 sh × $75.59
Exec Jan 16
Filed Jan 20 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $409K
9,549 sh × $42.80
Exec Aug 4 2025
Filed Aug 5 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $214K
6,523 sh × $32.79
Exec Jan 16 2025
Filed Jan 17 2025 · 5:30 PM ET